Myrexis, Inc. (MYRX)

OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
At close: Apr 27, 2026
-94.29%
Market Cap 13.79K
Revenue (ttm) n/a
Net Income (ttm) -11.62M
Shares Out 34.48M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 106
Average Volume 3,567
Open 0.0004
Previous Close n/a
Day's Range 0.0004 - 0.0004
52-Week Range 0.0001 - 0.0070
Beta 4.01
RSI 40.28
Earnings Date n/a

About Myrexis

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York. [Read more]

Industry Shell Companies
Sector Financials
CEO Jonathan Couchman
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol MYRX
Full Company Profile

Financial Performance

News

There is no news available yet.